Challenges associated with insulin therapy in type 2 diabetes mellitus
AbstractDespite advances in treatment for type 2 diabetes in recent decades, many patients are failing to achieve adequate glycemic control. Poor glycemic control has been shown to have a detrimental effect on patients’ health and well-being, and to have significant negative financial implications for both patients and healthcare systems. Insulin therapy has been proven to significantly reduce glycated hemoglobin levels; however, both patients and physicians can be reluctant to initiate insulin therapy. Research shows that both patient and provider factors contribute to a delay in initiation of insulin therapy. This review discusses the most common barriers contributing to this delay with potential solutions to overcome them.
Am. J. Med. – 2014. – Vol. 127, 10А. – Р. S11–S16. doi: 10.1016/j.amjmed.2014.07.003
Keywords:adherence, barriers, hypoglycemia, insulin, type 2 diabetes
Dear readers!
Full-text version of the article is available only in paper version.